Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.37 is 221% above its 5-year average of -1.13, near the high end of its 5-year range (-1.76–1.37).
211.38% above its 12-month average of -1.23.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.84.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:33:41.635Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.37
EARNINGS PER SHARE (EPS) AVG TTM
-1.23
EARNINGS PER SHARE (EPS) AVG 3Y
-1.08
EARNINGS PER SHARE (EPS) AVG 5Y
-1.13
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+211.38%
CURRENT VS 3Y AVG
+226.27%
CURRENT VS 5Y AVG
+220.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Liquidia Corporation
Market Cap
$2.36B
Earnings Per Share (EPS)
1.37
TTM Avg
-1.23
3Y Avg
-1.08
5Y Avg
-1.13
Market Cap
$2.38B
Earnings Per Share (EPS)
-3.45
TTM Avg
-2.96
3Y Avg
-3.07
5Y Avg
-2.96
Market Cap
$2.38B
Earnings Per Share (EPS)
0.70
TTM Avg
0.73
3Y Avg
0.23
5Y Avg
-0.12
Market Cap
$2.32B
Earnings Per Share (EPS)
3.08
TTM Avg
2.66
3Y Avg
2.64
5Y Avg
2.23
Market Cap
$2.41B
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.13
3Y Avg
-0.35
5Y Avg
-0.53
Market Cap
$2.43B
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.56
3Y Avg
-1.52
5Y Avg
-1.27
Market Cap
$2.29B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.98
3Y Avg
-0.30
5Y Avg
0.08
Market Cap
$2.42B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.45
3Y Avg
-0.45
5Y Avg
-0.45
Market Cap
$2.47B
Earnings Per Share (EPS)
-6.60
TTM Avg
-4.98
3Y Avg
-14.61
5Y Avg
-21.72
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.36B | 1.37 | -1.23 | -1.08 | -1.13 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | -3.45 | -2.96 | -3.07 | -2.96 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.38B | 0.70 | 0.73 | 0.23 | -0.12 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.32B | 3.08 | 2.66 | 2.64 | 2.23 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | -0.04 | -0.13 | -0.35 | -0.53 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -1.04 | -1.56 | -1.52 | -1.27 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | -0.54 | -0.98 | -0.30 | 0.08 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.42B | N/A | -0.45 | -0.45 | -0.45 |
| Disc Medicine, Inc. (IRON)vs › | $2.47B | -6.60 | -4.98 | -14.61 | -21.72 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | -3.14 | -3.03 | -2.85 | -2.34 |
Trailing EPS (TTM)
$1.37
Forward EPS (Est.)
$2.49
P/E Ratio
19.4
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.80 |
| 2024-12-31 | -1.66 |
| 2023-12-31 | -1.21 |
| 2022-12-31 | -0.67 |
| 2021-12-31 | -0.70 |
| 2020-12-31 | -1.76 |
| 2019-12-31 | -2.51 |
| 2018-12-31 | -7.42 |
| 2017-12-31 | -3.40 |
| 2016-12-31 | -1.86 |
